(EMAILWIRE.COM, February 08, 2019 ) Biobanking plays an integral role in advancing biomedical and translational research, through the collection and preservation of biological samples, such as blood, tissues, and nucleic acids, which are then made available for use in research to discover disease-relevant biomarkers; this is further used for diagnosis, prognosis, and predicting drug responses. Growth in the number of research activities in this segment forms a major driver for the market.

Download PDF: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=594

The objectives of this study are as follows:

- To define, describe, and forecast the market by product and service, sample type, storage type, application, and region

- To provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and challenges)

- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market

- To analyze the opportunities in the market for stakeholders and provide details of a competitive landscape for market leaders

- To forecast revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW)

Major industry players:

Hamilton Company (U.S.), Thermo Fisher Scientific Inc. (U.S.), Brooks Automation (U.S.), and Panasonic Healthcare Holdings Co. Ltd (Japan) have been identified as the top players in this market.

Read More: https://www.marketsandmarkets.com/Market-Reports/biobanking-devices-market-594.html